Fund Card

Fund Card

Mirae Asset Healthcare Fund-Reg(G)

As on Jan-16-2020 change fund
11.37  up0.08 (0.74%)

fund objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.

riskometer

Investors understand that their principal will be at high risk

5-Years History
financial year2018-20192019-2020
NAV in Rs (as on 16-Jan-2020)10.6611.37
Net Assets(Rs Crores) (as on 16-Jan-2020) 344.94 366.91
Scheme Returns(%)(Absolute)6.556.35
B'mark Returns(%)(Absolute)7.46-3.31
Category Rank25/7331/75
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2019-2020-6.180.878.30NA
2018-2019NANA-3.663.80
Top 10 holdings
company (%)
Sun Pharmaceutical Industries...12.50 
Divis Laboratories Ltd.9.58 
Dr. Reddys Laboratories Ltd.7.75 
Ipca Laboratories Ltd.7.67 
Cipla Ltd.7.39 
Biocon Ltd.6.82 
Torrent Pharmaceuticals Ltd.5.36 
Ajanta Pharma Ltd.4.46 
Dr. Lal Pathlabs Ltd.4.31 
Syngene International Ltd.4.14 

Category

Sector Funds

Launch Date

02-Jul-18

Scheme Benchmark

S&P BSE HEALTH CARE - TRI

AUM ( in Cr.)

366.91

portfolio price to book value

4.88

investing style?

Mid Growth

fund manager?

Vrijesh Kasera

inception date (regular plan)

02-Jul-18

expense ratio (regular plan) %

2.43

Alpha [%]

0.00

Beta [%]

0.48

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs77.20
Chemicals 10.10
Hospital & Healthcare Services4.31
Miscellaneous4.14
Finance - Others1.79
Insurance1.71

Historical NAV Chart with Benchmark

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes
scheme name investment style inception date AUM in Cr. 1W(%) 1M(%) 3M(%) 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
Mirae Asset Healthcare Fund-Reg(G)Mid-Growth 02-Jul-2018366.912.395.2712.898.37NANANA8.67BUYSIP
Nippon India Pharma Fund(G)Mid-Growth 05-Jun-20042,416.992.263.219.961.895.314.1013.3919.20BUYSIP
Tata India Pharma & Healthcare Fund-Reg(G)Mid-Growth 28-Dec-2015166.082.123.288.147.452.73NANA-1.31BUYSIP
UTI Healthcare Fund-Reg(G)Mid-Growth 01-Aug-2005394.612.474.4913.342.910.350.7210.9316.23BUYSIP
SBI Healthcare Opp Fund-Reg(G)Mid-Growth 14-Jul-1999926.472.103.8412.03-0.72-2.690.4612.7913.90BUYSIP
DSP Healthcare Fund-Reg(G)Mid-Growth 30-Nov-2018243.423.237.0714.8210.71NANANA12.20BUYSIP
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Mid-Growth 13-Jul-20181,286.902.684.2812.846.88NANANA4.70BUYSIP
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Mid-Growth 10-Jul-2019171.462.143.588.82NANANANA9.80BUYSIP
IDBI Healthcare Fund-Reg(G)Mid-Growth 28-Feb-201931.321.873.6210.57NANANANA8.80BUYSIP

Copyright © 2017 Vedant Asset. All Right Reserved.

Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not an indicator of future returns. ARN-104974